PROQR THERAPEUTICS N.V. Ordinary Shares (nominal value €0.04 per share) Sales AgreementSales Agreement • March 31st, 2020 • ProQR Therapeutics N.V. • Pharmaceutical preparations • New York
ProQR Therapeutics N.V., a Dutch public company with limited liability (the “Company”), confirms its agreement (this “Agreement”) with Citigroup Global Markets Inc. and Cantor Fitzgerald & Co. (each, an “Agent” and together, the “Agents”), as follows:
SUPPLY AND SERVICES AGREEMENTSupply and Services Agreement • March 31st, 2020 • ProQR Therapeutics N.V. • Pharmaceutical preparations
THIS SUPPLY AND SERVICES AGREEMENT is effective as of July 12th, 2019 (the “Effective Date”) and is made by and between ProQR Therapeutics IV B.V., having an office at Zernikedreef 9, 2333 CK Leiden, The Netherlands (“CUSTOMER”) and Nitto Denko Avecia Inc. (“AVECIA”), having an office at 125 Fortune Boulevard, Milford, MA 01757. CUSTOMER and AVECIA are sometimes referred to herein individually as a “Party” and collectively as “Parties”.
ASSET PURCHASE AGREEMENT among WINGS THERAPEUTICS, INC., PROQR THERAPEUTICS I B.V., PROQR THERAPEUTICS VII B.V., PROQR THERAPEUTICS HOLDING B.V. and PROQR THERAPEUTICS, N.V. Dated as of May 22, 2019 This document is intended solely to facilitate...Asset Purchase Agreement • March 31st, 2020 • ProQR Therapeutics N.V. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT, dated as of May 22, 2019, is among WINGS THERAPEUTICS, INC., a Delaware corporation (“Purchaser”), PROQR THERAPEUTICS I B.V., a company organized under the laws of The Netherlands (“ProQR I”), PROQR THERAPEUTICS VII B.V., a company organized under the laws of The Netherlands (“ProQR VII”), PROQR THERAPEUTICS HOLDING B.V., a company organized under the laws of The Netherlands and sole equity owner of ProQR I and PROQR VII (“Holding” and together with ProQR I and PROQR VII, each a “Seller” and together the “Sellers”), and, solely for purposes of Article VI, PROQR THERAPEUTICS N.V., a company organized under the laws of The Netherlands and sole equity owner of Holding (“Parent”). Capitalized terms used herein have the meanings ascribed to them in Section 7.07.
SUBSCRIPTION AGREEMENTSubscription Agreement • March 31st, 2020 • ProQR Therapeutics N.V. • Pharmaceutical preparations
This SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of May 22, 2019 (the “Effective Date”), is made by and between Wings Therapeutics, Inc., a Delaware corporation (the “Company”), and ProQR Therapeutics Holding B.V., a company organized under the laws of The Netherlands (“ProQR”).
Lease Agreement between Leeds Investment I B.V. and ProQR Therapeutics I B.V. Zernikedreef 9 LeidenLease Agreement • March 31st, 2020 • ProQR Therapeutics N.V. • Pharmaceutical preparations
This model may only be referred to and utilised if the text that has been filled in, added or modified is clearly recognisable as such. Any additions and amendments should preferably be incorporated under the heading ‘Special Provisions’. ROZ accepts no responsibility for adverse consequences arising from the use of the text of the model.
